Characterization of the Neuroendocrine Tumor Immune Microenvironment

Annacarolina Da Silva, Michaela Bowden, Sui Zhang, Yohei Masugi, Aaron R. Thorner, Zachary T. Herbert, Chensheng Willa Zhou, Lauren Brais, Jennifer A. Chan, F. Stephen Hodi, Scott Rodig, Shuji Ogino, Matthew H. Kulke

研究成果: Article査読

25 被引用数 (Scopus)


Objectives The immune environment and the potential for neuroendocrine tumors (NETs) to respond to immune checkpoint inhibitors remain largely unexplored. We assessed immune checkpoint marker expression, lymphocytic infiltrate, and associated mutational profiles in a cohort of small intestine and pancreatic NETs. Methods We assessed expression of PDCD1 (PD-1), CD274 (PD-L1), and PDCD1LG2 (PD-L2) in archival tissue from 64 small intestine (SINETs) and 31 pancreatic NETs (pNET). We additionally assessed T-cell infiltrates, categorizing T-cell subsets based on expression of the T-cell markers CD3, CD8, CD45RO (PTPRC), or FOXP3. Finally, we explored associations between immune checkpoint marker expression, lymphocytic infiltrate, and tumor mutational profiles. Results Expression of PD-1 or PD-L1 in small intestine or pancreatic NET was rare, whereas expression of PD-L2 was common in both NET subtypes. T-cell infiltrates were more abundant in pNET than in SINET. We found no clear associations between immune checkpoint marker expression, immune infiltrates, and specific mutational profile within each tumor type. Conclusions Our findings provide an initial assessment of the immune environment of well-differentiated NETs. Further studies to define the immunologic differences between pNET and SINET, as well as the role of PD-L2 in these tumors, are warranted.

出版ステータスPublished - 2018 10 1

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Hepatology
  • Endocrinology

フィンガープリント 「Characterization of the Neuroendocrine Tumor Immune Microenvironment」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。